Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |